You are here
CureVac says COVID vaccine produced immune response in early-stage trial
Primary tabs
Fri, 2023-01-06 22:19 — mike kraft
CureVac says COVID vaccine produced immune response in early-stage trial Germany's CureVac AG said on Friday its second-generation COVID-19 vaccine produced virus-neutralizing antibodies against the BA.1 subvariant of Omicron, based on preliminary data from an early-stage trial. Reuters
...
The company said the vaccine was shown to be generally well tolerated in the trial. Younger adults showed the presence of neutralizing antibodies beginning at the lowest tested dose, data showed.
...
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments